Abstract
Background Autism is a partially heritable neurodevelopmental condition, and people with autism may also have other co-occurring conditions such as ADHD, anxiety disorders, depression, mental health issues, learning difficulty, physical health conditions and communication challenges. The concomitant development of autism and other neurological conditions is assumed to result from a complex interplay between genetics and the environment. However, only a limited number of studies have performed analysis on multivariate genetic autism associations.
Methods We conducted to-date the largest multivariate GWAS on autism and 8 autism co-occurring condition traits (ADHD, ADHD childhood, anxiety stress, bipolar, disruptive behaviour, educational attainment, major depression, and schizophrenia) using summary statistics from leading studies. Multivariate associations and central traits were further identified. Subsequently, colocalization and Mendelian randomization (MR) analysis were performed on the associations identified with the central traits containing autism. To further validate our findings, pathway and quantified trait loci (QTL) resources as well as independent datasets consisting of 92 (30 probands) whole genome sequence data from the GEMMA project were utilized.
Results Multivariate GWAS resulted in 637 significant associations (p < 5e-8), among which 322 are reported for the first time for any trait. 37 SNPs were identified to contain autism and one or more traits in their central trait set, including variants mapped to known SFARI autism genes MAPT and NEGR1 as well as novel ASD genes KANSL1, NSF and NTM, associated with immune response, synaptic transmission, and neurite growth respectively. Mendelian randomization analyses found that all 8 co-occuring conditions are associated with autism while colocalization provided strong evidence of shared genetic aetiology between autism and education attainment, schizophrenia and bipolar traits. Allele proportions differences between MAPT (17q21.31) region aberrations and MAPT H1/H2 haplotypes, known to associate with neurodevelopment wwere found between GEMMA autism probands and controls. Pathway, QTL and cell type enrichment implicated microbiome, enteric inflammation, and central nervous system enrichments.
Conclusions Our study, combining multivariate genome-wide association testing with systematic decomposition identified novel genetic associations related to autism and autism co-occurring driver traits. Statistical tests were applied to discern evidence for shared and interpretable liability between autism and co-occurring traits. These findings expand upon the current understanding of the complex genetics regulating autism and reveal insights of neuronal brain disruptions potentially driving development and manifestation.
Highlights:
Multivariate GWAS resulted in 637 significant ASD associations (p < 5e-8), among which 322 are reported for the first time.
The novel associations mapped to known SFARI autism genes MAPT and NEGR1 and novel ASD markers KANSL1, NSF and NTM markers, associated with immune response, synaptic transmission, and neurite growth, potentially driving the gut brain-barrier hypothesis driving ASD.
Mendelian randomization analyses found that the co-occuring traits ADHD, ADHD childhood, anxiety stress, bipolar, disruptive behaviour, educational attainment, major depression, and schizophrenia are strongly associated with autism.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The work was supported by European Commission Horizon 2020 programme (grant no. 825033)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
↵* Equal contributions
LDSC was employed to select and filter ASD related traits based on genetic correlation. MTAG was applied to validate multivariate GWAS signals yielded from MetaPhat/MetaCCA. Selected associations were further assessed using QTL. Larger sample sizes from GEMMA were integrated into the validation step.
Data Availability
All suumary data produced in the present study are available upon reasonable request to the authors
